CN106389477A - 一种土生戈登氏菌的全细胞植物油提取物的制备方法和应用 - Google Patents
一种土生戈登氏菌的全细胞植物油提取物的制备方法和应用 Download PDFInfo
- Publication number
- CN106389477A CN106389477A CN201611048359.1A CN201611048359A CN106389477A CN 106389477 A CN106389477 A CN 106389477A CN 201611048359 A CN201611048359 A CN 201611048359A CN 106389477 A CN106389477 A CN 106389477A
- Authority
- CN
- China
- Prior art keywords
- gordonia terrae
- vegetable oil
- terrae
- tank
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000203747 Gordonia terrae Species 0.000 title claims abstract description 60
- 239000000284 extract Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 13
- 239000008158 vegetable oil Substances 0.000 title claims abstract description 13
- 241000894006 Bacteria Species 0.000 claims abstract description 28
- 239000000843 powder Substances 0.000 claims abstract description 19
- 230000029663 wound healing Effects 0.000 claims abstract description 14
- 238000000855 fermentation Methods 0.000 claims abstract description 13
- 230000004151 fermentation Effects 0.000 claims abstract description 13
- 238000010899 nucleation Methods 0.000 claims abstract description 10
- 238000011081 inoculation Methods 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 244000061458 Solanum melongena Species 0.000 claims abstract description 4
- 235000002597 Solanum melongena Nutrition 0.000 claims abstract description 4
- 238000005119 centrifugation Methods 0.000 claims abstract description 4
- 230000001413 cellular effect Effects 0.000 claims description 31
- 239000010773 plant oil Substances 0.000 claims description 30
- 239000003814 drug Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 206010053615 Thermal burn Diseases 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 230000002779 inactivation Effects 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 238000000386 microscopy Methods 0.000 claims description 3
- 238000011218 seed culture Methods 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 235000011803 sesame oil Nutrition 0.000 claims description 3
- 239000008159 sesame oil Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 208000000440 Herpetic Stomatitis Diseases 0.000 abstract 1
- 206010067152 Oral herpes Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 description 16
- 206010052428 Wound Diseases 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000003304 gavage Methods 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 4
- 238000011047 acute toxicity test Methods 0.000 description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 235000013734 beta-carotene Nutrition 0.000 description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 4
- 239000011648 beta-carotene Substances 0.000 description 4
- 229960002747 betacarotene Drugs 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 238000009924 canning Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 4
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 3
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 3
- 241000186359 Mycobacterium Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 150000001747 carotenoids Chemical class 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000203749 Gordonia bronchialis Species 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000003305 oral gavage Methods 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 150000003071 polychlorinated biphenyls Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000002992 thymic effect Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 101001043827 Mus musculus Interleukin-2 Proteins 0.000 description 1
- 101100046526 Mus musculus Tnf gene Proteins 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- -1 compound amino acid Chemical class 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 125000003843 furanosyl group Chemical group 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 210000000955 splenic vein Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
Abstract
Description
1 | 2 | 3 | 4 | 5 | |
CK组 | 86.9 | 103.1 | 131.5 | 152.1 | 129.6 |
实验组 | 203.4 | 217.4 | 227.6 | 257.2 | 266.1 |
1 | 2 | 3 | 4 | 5 | |
CK组 | 138.0 | 160.1 | 196.7 | 210.9 | 233.5 |
实验组 | 331.6 | 369.5 | 389.7 | 432.2 | 483.8 |
组别 | 小鼠个数N | 生理盐水 | conA诱导 |
CK | 20 | 3800±437 | 11258±1713 |
0.0001 | 14 | 8343±402 | 18307±3143 |
0.001 | 14 | 11286±2317 | 24532±4315 |
0.01 | 14 | 12688±1302 | 29563±2811 |
组别 | 例组 | 止疱/d | 结痂/d | 脱痂/d | 总病程/d |
试验组 | 10 | 1.5±0.35 | 2.5±0.5 | 5.5±0.35 | 5.8±0.5 |
对照组 | 10 | 3.03±0.25 | 5.10±1.13 | 6.22±1.20 | 6.7±1.35 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611048359.1A CN106389477B (zh) | 2016-11-23 | 2016-11-23 | 一种土生戈登氏菌的全细胞植物油提取物的制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611048359.1A CN106389477B (zh) | 2016-11-23 | 2016-11-23 | 一种土生戈登氏菌的全细胞植物油提取物的制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106389477A true CN106389477A (zh) | 2017-02-15 |
CN106389477B CN106389477B (zh) | 2018-04-20 |
Family
ID=58082742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611048359.1A Active CN106389477B (zh) | 2016-11-23 | 2016-11-23 | 一种土生戈登氏菌的全细胞植物油提取物的制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106389477B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107259274A (zh) * | 2017-07-28 | 2017-10-20 | 张可池 | 一种凤眼果复方饮料 |
CN113249248A (zh) * | 2021-04-25 | 2021-08-13 | 西华大学 | 一种暗红戈登氏菌、用途及生产色素的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1207416A (zh) * | 1998-07-02 | 1999-02-10 | 张素琴 | 生态平衡营养精活素及其生产方法 |
CN1442151A (zh) * | 2003-04-04 | 2003-09-17 | 张素琴 | 麦可芙莱免疫液 |
US20090226490A1 (en) * | 2005-12-21 | 2009-09-10 | John Lawson Stanford | Use of Whole Bacterial Cells (Actinomycetales) for Maternal Administration to Modulate Offspring Immune Response |
CN103555630A (zh) * | 2013-11-05 | 2014-02-05 | 张素琴 | 一种中华戈登氏菌及制备方法和应用 |
-
2016
- 2016-11-23 CN CN201611048359.1A patent/CN106389477B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1207416A (zh) * | 1998-07-02 | 1999-02-10 | 张素琴 | 生态平衡营养精活素及其生产方法 |
CN1442151A (zh) * | 2003-04-04 | 2003-09-17 | 张素琴 | 麦可芙莱免疫液 |
US20090226490A1 (en) * | 2005-12-21 | 2009-09-10 | John Lawson Stanford | Use of Whole Bacterial Cells (Actinomycetales) for Maternal Administration to Modulate Offspring Immune Response |
CN103555630A (zh) * | 2013-11-05 | 2014-02-05 | 张素琴 | 一种中华戈登氏菌及制备方法和应用 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107259274A (zh) * | 2017-07-28 | 2017-10-20 | 张可池 | 一种凤眼果复方饮料 |
CN113249248A (zh) * | 2021-04-25 | 2021-08-13 | 西华大学 | 一种暗红戈登氏菌、用途及生产色素的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106389477B (zh) | 2018-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101624570B (zh) | 中药培养养殖肉灵芝方法及养殖肉灵芝保健品的制备方法 | |
CN101760478A (zh) | 一种葛根红曲的制造方法 | |
CN103141702B (zh) | 一种可有效防治猪流行性腹泻的中草药提取物饲料添加剂 | |
CN104623122B (zh) | 一种具有抗疲劳功能的生物制剂及其制作方法 | |
CN106265763A (zh) | 具有延缓衰老和美容养颜功能的组合物及其应用 | |
CN104524024A (zh) | 一种用于改善男性精子质量的复合微生物制剂及其制备方法 | |
CN104922586A (zh) | 一种防治鸡球虫病的益生菌发酵中药制剂的制备及其应用 | |
CN104739919A (zh) | 一种发酵黄芪复合制剂及其制备方法与应用 | |
CN102552335A (zh) | 一种中药保健品及其制备方法和应用 | |
CN112057546A (zh) | 一种蜂胶灵芝孢子粉组合物及其制备方法和应用 | |
CN104799286B (zh) | 一种用于提高免疫力的组合物及其制备方法 | |
CN104083427A (zh) | 防治禽流感的复方黄芪多糖颗粒 | |
CN103083510A (zh) | 一种提高禽免疫功能的中药口服液及其制备方法 | |
WO2015190872A1 (ko) | 스피루리나 추출물을 유효성분으로 함유하는 비만 예방 및 치료용 약학적 조성물 | |
CN106389477B (zh) | 一种土生戈登氏菌的全细胞植物油提取物的制备方法和应用 | |
CN105664140A (zh) | 一种糖肽组合物及其制备方法和用途 | |
CN103238757B (zh) | 一种含发酵棉粕的蛋鸡配合饲料及其制备方法 | |
CN107095300A (zh) | 一种辅助治疗糖尿病的生物营养配方组合物 | |
CN104940241B (zh) | 一种防治妇女更年期综合征的硒虫草复方制剂 | |
CN103932179B (zh) | 一种缓解压力及护肝的保健食品及其二步发酵制备方法 | |
CN110859871A (zh) | 一种用于前列腺炎的组合物及其制备方法 | |
CN104799289A (zh) | 具有抗肿瘤提高免疫功能的复合营养食品及其生产方法 | |
CN115252768A (zh) | 一种改善男性生殖能力的组合物、制备方法和应用 | |
CN107893035A (zh) | 一种猴头菌的培养基、黄精生物转化菌丝体、黄精生物转化菌丝体的提取物及其用途 | |
CN108379446B (zh) | 具有辅助治疗男性少弱精子症的辅酶q10制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180313 Address after: Room 523, room No. 1, B District, B District, Wuhan, East Lake New Technology Development Zone, Wuhan City, Hubei Applicant after: Wuhan Qi Yao Biological Technology Co.,Ltd. Address before: 430079 Hubei City, Wuhan Province, East Lake Development Zone, hung Chu street, No. 998, No. 10 Online sunshine 2-402 Applicant before: WUHAN QIYAO ENVIRONMENTAL TECHNOLOGY CO.,LTD. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190710 Address after: 430042 No. 43, Maomiao Market Street, Baiquan, Dongxihu District, Wuhan City, Hubei Province (9) Patentee after: Wuhan Taoyuanfeng Holding Co.,Ltd. Address before: 430000 Room 523, Building 1, B, Headquarters of Gaonong Biological Park, 888 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee before: Wuhan Qi Yao Biological Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191129 Address after: 430000 room b011, public service center, daolongquan mountain scenic spot, 004 County, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan runshui Environmental Technology Co.,Ltd. Address before: 430042 No. 43, Maomiao Market Street, Baiquan, Dongxihu District, Wuhan City, Hubei Province (9) Patentee before: Wuhan Taoyuanfeng Holding Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230627 Address after: No. 64-5-10, Xiaohongshan District, Wuchang District, Wuhan City, Hubei Province 430000 Patentee after: Zhang Shimin Patentee after: Zhang Suqin Address before: 430000 room b011, public service center, Longquanshan scenic area, 004 County Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee before: Wuhan runshui Environmental Technology Co.,Ltd. |